• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

出版诚信:它是什么,为何重要,如何保障以及我们怎样能做得更好?

Publication integrity: what is it, why does it matter, how it is safeguarded and how could we do better?

作者信息

Bolland Mark J, Avenell Alison, Grey Andrew

机构信息

Department of Medicine, University of Auckland, Auckland, New Zealand.

Health Services Research Unit, University of Aberdeen, Foresterhill, Scotland.

出版信息

J R Soc N Z. 2024 Mar 13;55(2):267-286. doi: 10.1080/03036758.2024.2325004. eCollection 2025.

DOI:10.1080/03036758.2024.2325004
PMID:39677378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11639066/
Abstract

Trustworthy literature is an essential part of knowledge, evidence-based information, and science. However, publications can contain mistakes or have results from unreliable research, which may compromise their integrity. In this review, we discuss publication integrity, with a focus on our field of biomedicine, and how it could be improved. In our experience, compromised publication integrity is frequently poorly handled, and we, and others, have reported that responses to publication integrity concerns can be inefficient, inconsistent, slow, opaque, and incomplete. Checklists and tools are now available to assist in the assessment of publication integrity, but systemic changes are needed. However, this requires many of the key parties involved (journals, publishers, institutions, academic societies, and regulators) to acknowledge and engage with the problem. There is little evidence of a willingness to do this. We conclude that it has been recognised for many years that the system for dealing with publication integrity is broken, but currently, there appears little interest in trying to improve it.

摘要

可信的文献是知识、循证信息和科学的重要组成部分。然而,出版物可能包含错误或有不可靠研究的结果,这可能会损害其完整性。在本综述中,我们讨论出版诚信问题,重点关注我们的生物医学领域,以及如何加以改进。根据我们的经验,受损的出版诚信问题常常处理不当,而且我们以及其他人都报告说,对出版诚信问题的回应可能效率低下、不一致、缓慢、不透明且不完整。现在有清单和工具可协助评估出版诚信,但需要进行系统性变革。然而,这需要许多相关关键方(期刊、出版商、机构、学术团体和监管机构)认识到并应对这一问题。几乎没有证据表明他们愿意这样做。我们的结论是,多年来人们已经认识到处理出版诚信的体系存在问题,但目前,似乎几乎没有人有兴趣试图改进它。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066f/11639066/6fcc54506d1d/TNZR_A_2325004_F0004_OB.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066f/11639066/66ba66998343/TNZR_A_2325004_F0001_OB.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066f/11639066/1bba2a59788a/TNZR_A_2325004_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066f/11639066/ec4a544f3f36/TNZR_A_2325004_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066f/11639066/6fcc54506d1d/TNZR_A_2325004_F0004_OB.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066f/11639066/66ba66998343/TNZR_A_2325004_F0001_OB.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066f/11639066/1bba2a59788a/TNZR_A_2325004_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066f/11639066/ec4a544f3f36/TNZR_A_2325004_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/066f/11639066/6fcc54506d1d/TNZR_A_2325004_F0004_OB.jpg

相似文献

1
Publication integrity: what is it, why does it matter, how it is safeguarded and how could we do better?出版诚信:它是什么,为何重要,如何保障以及我们怎样能做得更好?
J R Soc N Z. 2024 Mar 13;55(2):267-286. doi: 10.1080/03036758.2024.2325004. eCollection 2025.
2
Procrastination and inconsistency: Expressions of concern for publications with compromised integrity.拖延和不一致:对有失诚信的出版物的关注表现。
Account Res. 2024 Dec;31(3):196-209. doi: 10.1080/08989621.2022.2112572. Epub 2022 Aug 18.
3
Ten Years later: Assessments of the integrity of publications from one research group with multiple retractions.十年后:对一个有多篇撤回论文的研究小组所发表论文完整性的评估。
Account Res. 2025 May;32(4):488-508. doi: 10.1080/08989621.2023.2295996. Epub 2023 Dec 20.
4
[The different models of scientific journals].[科学期刊的不同模式]
Med Trop Sante Int. 2023 Dec 8;3(4). doi: 10.48327/mtsi.v3i4.2023.454. eCollection 2023 Dec 31.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Correcting the scientific record - A broken system?纠正科学记录——一个破碎的系统?
Account Res. 2021 Jul;28(5):265-279. doi: 10.1080/08989621.2020.1852938. Epub 2020 Dec 8.
7
Timeliness and content of retraction notices for publications by a single research group.单个研究组发表的论文撤稿通知的及时性和内容。
Account Res. 2022 Aug;29(6):347-378. doi: 10.1080/08989621.2021.1920409. Epub 2021 May 5.
8
Correcting the literature following fraudulent publication.纠正欺诈性发表后的文献。
JAMA. 1990 Mar 9;263(10):1416-9.
9
Assessing and Raising Concerns About Duplicate Publication, Authorship Transgressions and Data Errors in a Body of Preclinical Research.评估和关注一组临床前研究中的重复发表、作者违规和数据错误。
Sci Eng Ethics. 2020 Aug;26(4):2069-2096. doi: 10.1007/s11948-019-00152-w. Epub 2019 Oct 31.
10
Cooperation & Liaison between Universities & Editors (CLUE): recommendations on best practice.大学与编辑之间的合作与联络(CLUE):最佳实践建议
Res Integr Peer Rev. 2021 Apr 15;6(1):6. doi: 10.1186/s41073-021-00109-3.

引用本文的文献

1
Can I trust this paper?我能信任这篇论文吗?
Psychon Bull Rev. 2025 Jul 16. doi: 10.3758/s13423-025-02740-3.
2
Publishers' Response to Post-Publication Concerns About Clinical Research in Women's Health.出版商对女性健康临床研究发表后引发的关注的回应。
BJOG. 2025 Jun;132(7):892-901. doi: 10.1111/1471-0528.18100. Epub 2025 Feb 26.

本文引用的文献

1
More than 10,000 research papers were retracted in 2023 - a new record.2023年有超过1万篇研究论文被撤回,创下了新纪录。
Nature. 2023 Dec;624(7992):479-481. doi: 10.1038/d41586-023-03974-8.
2
Dubious data and contamination of the research literature on pain.关于疼痛研究文献的数据存疑及污染问题。
Br J Pain. 2023 Aug;17(4):328-329. doi: 10.1177/20494637231190866. Epub 2023 Jul 17.
3
Checklist to assess Trustworthiness in RAndomised Controlled Trials (TRACT checklist): concept proposal and pilot.评估随机对照试验可信度的清单(TRACT清单):概念提案与试点。
Res Integr Peer Rev. 2023 Jun 20;8(1):6. doi: 10.1186/s41073-023-00130-8.
4
Distributions of baseline categorical variables were different from the expected distributions in randomized trials with integrity concerns.在存在诚信问题的随机试验中,基线分类变量的分布与预期分布不同。
J Clin Epidemiol. 2023 Feb;154:117-124. doi: 10.1016/j.jclinepi.2022.12.018. Epub 2022 Dec 27.
5
Identifying and managing problematic trials: A research integrity assessment tool for randomized controlled trials in evidence synthesis.识别和管理有问题的试验:证据综合中随机对照试验的研究诚信评估工具。
Res Synth Methods. 2023 May;14(3):357-369. doi: 10.1002/jrsm.1599. Epub 2022 Sep 15.
6
Prevalence of questionable research practices, research misconduct and their potential explanatory factors: A survey among academic researchers in The Netherlands.可疑研究行为、研究不端行为及其潜在解释因素的流行程度:荷兰学术研究人员的调查。
PLoS One. 2022 Feb 16;17(2):e0263023. doi: 10.1371/journal.pone.0263023. eCollection 2022.
7
Unsung Heroes of Research Integrity.科研诚信的无名英雄。
J Bone Miner Res. 2021 Dec;36(12):2287-2289. doi: 10.1002/jbmr.4474. Epub 2021 Nov 24.
8
Vitamin D deficiency, supplementation and testing: have we got it right in New Zealand?维生素 D 缺乏、补充和检测:新西兰是否做对了?
N Z Med J. 2021 Sep 3;134(1541):86-95.
9
Coronapod: The Surgisphere scandal that rocked coronavirus drug research.冠状病毒研究骗局:震动新冠病毒药物研究的Surgisphere丑闻。
Nature. 2020 Jun 12. doi: 10.1038/d41586-020-01790-y.
10
Identical summary statistics were uncommon in randomized trials and cohort studies.相同的汇总统计数据在随机试验和队列研究中并不常见。
J Clin Epidemiol. 2021 Aug;136:180-188. doi: 10.1016/j.jclinepi.2021.05.002. Epub 2021 May 15.